Table 1 Baseline characteristics among three groups

Age

60 (60,69)

68 (61,73)

69 (64,75)*

0.001

Male

36 (61%)

87 (63%)

73 (67%)

0.576

Height(cm)

164 (160,172)

167 (160,173)

168 (160,174)

0.448

Weight(kg)

66 ± 10

68 ± 11

69 ± 11

0.212

BMI(kg/m²)

24.1 ± 3.0

24.6 ± 3.1

24.8 ± 3.4

0.378

BSA(m²)

1.73 ± 0.16

1.76 ± 0.17

1.77 ± 0.19

0.263

SBP(mmHg)

130 (120,139)

133 (122,143)

132 (120,142)

0.105

DBP(mmHg)

81 (75,86)

80 (74,85)

80 (75,89)

0.583

HR(bpm)

69 (63,76)

67 (60,73)

77 (64,91)*†

< 0.001

 CHF

0

4 (2.9%)

17 (15.6%)*†

< 0.001

 Hypertension

13 (22%)

84 (60%)*

76 (70%)*

< 0.001

 T2DM

4 (7%)

22 (16%)

30 (27%)*

0.002

 CAD

0

24 (17%)*

36 (33%)*†

< 0.001

 Stroke

0

17 (12%)*

34 (31%)*†

< 0.001

 PVD

0

2 (1%)

4 (2%)

0.411

AF duration (month)

/

24 (2,60)

48 (5,91)

0.016

CHA₂DS₂-VASc

/

2 (1,4)

3 (2,5)

< 0.001

NT pro-BNP

/

120 (39,444)

956 (520,1918)

< 0.001

 Type I

/

32 (23%)

4 (4%)

< 0.001

 Type II

/

52 (37%)

43 (39%)

0.743

 Type III

/

35 (25%)

7 (6%)

< 0.001

Anticoagulant therapy

/

66 (47%)

46 (42%)

0.407

Ablation

/

17 (13%)

5 (5%)

0.029